Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06842680 · ClinicalTrials.gov registry record · NA
Testing Ultraprocessed Food Labels in Chile
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 3,645
- Enrollment target
NCT06842680: Completed NA study, sponsored by University of North Carolina, Chapel Hill.
NCT06842680 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 3,645 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (160% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06842680, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,645 participants
- Enrollment target
Study Summary
The goal of this experiment is to examine the effects of a warning label signaling that a product is ultraprocessed among a sample of Chilean parents. The main questions this experiment aims to answer are: Do ultraprocessed warning labels on their own impact product purchase intentions? Do ultraprocessed warning labels impact product purchase intentions in the presence of nutrient warning labels? Do ultraprocessed warning labels help more consumers identify ultraprocessed foods? Participants will be randomly assigned to a control arm or an ultraprocessed warning label arm. In both arms, products will carry nutrient warning labels, which are Chile's current policy. Participants will see three similar products, all of which will be ultraprocessed: one not high in any nutrients of concern, one high in sodium, and one high in sodium and saturated fat. For each product, participants will rate their purchase intentions and indicate whether they believe the product to be ultraprocessed. Researchers will compare results across arms.
Primary Outcome
How likely the participant would be to buy products will be measured by survey. Response options will be on a 5-point scale from "very unlikely" (coded as 1) to "very likely" (coded as 5), with higher scores representing a higher likelihood of buying products.
Interventions
- BEHAVIORAL Control
- BEHAVIORAL Ultraprocessed warning label
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,645 participants |
| Start Date | 2025-07-14 |
| Est. Completion | 2025-08-31 |
| Phase | NA |
What the finished NCT06842680 record still lists
NCT06842680 is an interventional study that assigns participants to a tested intervention. Its 3,645 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (160% higher).
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT06842680 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06842680 about?
NCT06842680 is a clinical study titled "Testing Ultraprocessed Food Labels in Chile". The goal of this experiment is to examine the effects of a warning label signaling that a product is ultraprocessed among a sample of Chilean parents. The main questions this experiment aims to answer are: Do ultraprocessed warning labels on their own impact product purchase intentions? Do ultrapr...
What is the current status of trial NCT06842680?
This trial is currently completed. It is a NA study. The enrollment target is 3,645 participants. The study started on 2025-07-14. Estimated completion is 2025-08-31.
What interventions are being tested in trial NCT06842680?
The interventions under investigation include: Control (BEHAVIORAL), Ultraprocessed warning label (BEHAVIORAL).
Who is sponsoring clinical trial NCT06842680?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06842680's enrollment target sits among peer trials
3,645 36th of 2000 higher than 1,965 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06702553 · 3,650 participants · Phase 3
Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass
- NCT07249398 · 3,650 participants · NA
Influence of Social Media Ads on Food Choice - Master Protocol
- NCT06354920 · 3,624 participants · NA
M-Well Bonding Bundle to Improve Patient-Physician Relationships
- NCT06058377 · 3,680 participants · Phase 3
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI